MyFinsight
Home
Compare
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
|
Compare
Income Overview
Net Income
-$53,146,000
EPS
-$1.74
Unit: Dollar
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
Collaboration revenue
0
0
Research and development
36,226,000
32,321,000
General and administrative
10,511,000
7,350,000
Change in fair value of contingent consideration
8,733,000
109,000
Total operating expenses
55,470,000
39,780,000
Operating loss
-55,470,000
-39,780,000
Interest income
2,832,000
1,708,000
Interest expense
20,000
10,000
Other expense, net
-138,000
-117,000
Total other income, net
2,674,000
1,581,000
Loss before income taxes
-52,796,000
-38,199,000
Income tax provision
-8,000
63,000
Net loss
-52,788,000
-38,262,000
Foreign currency translation adjustment
113,000
-306,000
Unrealized gain (loss) on marketable securities, net of tax
-471,000
-86,000
Total other comprehensive (loss) income
-358,000
-392,000
Comprehensive loss
-53,146,000
-38,654,000
Basic EPS
-1.74
-6.77
Diluted EPS
-1.74
-6.77
Basic Average Shares
30,277,051
5,655,716
Diluted Average Shares
30,277,051
5,655,716
Page 1
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Comprehensive loss
-$53,146,000
Net loss
-$52,788,000
Total other
comprehensive (loss) income
-$358,000
Income tax provision
-$8,000
Foreign currency
translation adjustment
$113,000
Interest income
$2,832,000
Loss before income
taxes
-$52,796,000
Unrealized gain (loss) on
marketable securities, net...
-$471,000
Total other income,
net
$2,674,000
Other expense, net
-$138,000
Interest expense
$20,000
Operating loss
-$55,470,000
Total operating
expenses
$55,470,000
Research and development
$36,226,000
General and
administrative
$10,511,000
Change in fair value of
contingent consideration
$8,733,000
Buy us a coffee
Odyssey Therapeutics, Inc. (ODTX)
Odyssey Therapeutics, Inc. (ODTX)